3 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Cardiogenic Shock: new trials by email Literature Review of Cardiogenic Shock trials Research Report on Cardiogenic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support Ivabradine 7.5Mg Tab, DOBUTamine Injectable Solution - Heart Failure, Cardiogenic Shock | Phase 3 | Unknown | The Young Investigator Group of Cardiovascular Research | 200 | 2022-07-01 | 2022-10-26 |
| Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock Norepinephrine - Cardiogenic Shock | Phase 3 | Unknown | Central Hospital, Nancy, France | 40 | 2018-01-15 | 2017-11-14 |
| Levosimendan Versus Dobutamine in Shock Patients Levosimendan, Dobutamine - Cardiogenic Shock, Septic Shock | Phase 2 / Phase 3 | Unknown | Wentworth Area Health Services | 40 | 2004-10-01 | 2005-06-24 |
Shock, Cardiogenic (3) · Heart Failure (2) · Shock (2) · Myocardial Ischemia (1) · Sepsis (1) · Shock, Septic (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Infarction (3) · Ischemia (3) · Myocardial Infarction (3) · Necrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Vascular Diseases (3) · Myocardial Ischemia (2) · Infections (1) · Inflammation (1) · Shock (1) · Systemic Inflammatory Response Syndrome (1)
Dobutamine (3) · Ivabradine (1) · Norepinephrine (1) · Simendan (1)
Central Hospital, Nancy, France (1) · The Young Investigator Group of Cardiovascular Research (1) · Wentworth Area Health Services (1)
Australia (1) · Egypt (1) · France (1)
2017 (1)